{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:39:58Z","timestamp":1793907598961,"version":"4.8.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-025-02789-3","type":"journal-article","created":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T07:59:14Z","timestamp":1749887954000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Beyond overweight, visceral adiposity is associated with estimation of cardiovascular risk in patients living with type 1 diabetes: findings from the SFDT1 cohort"],"prefix":"10.1186","volume":"24","author":[{"given":"Laurence","family":"Salle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Baptiste","family":"Julla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Fagherazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Gourdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Bezerra Parente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Hanaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sopio","family":"Tatulashvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Disse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Franc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samy","family":"Hadjadj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Larger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Vaduva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Valero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Bonnefond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Cosson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria A.","family":"Aguayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Riveline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the SFDT1 group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,14]]},"reference":[{"key":"2789_CR1","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1056\/NEJMoa1608664","volume":"376","author":"A Rawshani","year":"2017","unstructured":"Rawshani A, Rawshani A, Franz\u00e9n S, Eliasson B, Svensson A-M, Miftaraj M, et al. Mortality and cardiovascular disease in type 1 and Type 2 Diabetes. N Engl J Med. 2017;376:1407\u201318.","journal-title":"N Engl J Med"},{"key":"2789_CR2","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1056\/NEJMoa1408214","volume":"371","author":"M Lind","year":"2014","unstructured":"Lind M, Svensson A-M, Kosiborod M, Gudbj\u00f6rnsdottir S, Pivodic A, Wedel H, et al. Glycemic control and excess mortality in type 1 diabetes. N Engl J Med. 2014;371:1972\u201382.","journal-title":"N Engl J Med"},{"key":"2789_CR3","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1161\/CIRCULATIONAHA.116.025961","volume":"135","author":"A Rawshani","year":"2017","unstructured":"Rawshani A, Rawshani A, Franz\u00e9n S, Eliasson B, Svensson A-M, Miftaraj M, et al. Range of risk factor levels: control, mortality, and cardiovascular outcomes in type 1 diabetes mellitus. Circulation. 2017;135:1522\u201331.","journal-title":"Circulation"},{"key":"2789_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1015614","author":"I Genua","year":"2022","unstructured":"Genua I, Franch-Nadal J, Navas E, Mata-Cases M, Gim\u00e9nez-P\u00e9rez G, Vlacho B, et al. Obesity and related comorbidities in a large population-based cohort of subjects with type 1 diabetes in Catalonia. Front Endocrinol. 2022. https:\/\/doi.org\/10.3389\/fendo.2022.1015614.","journal-title":"Front Endocrinol"},{"key":"2789_CR5","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1089\/dia.2021.0003","volume":"23","author":"A Lavens","year":"2021","unstructured":"Lavens A, Nobels F, De Block C, Oriot P, Verhaegen A, Chao S, et al. Effect of an integrated, multidisciplinary nationwide approach to type 1 diabetes care on metabolic outcomes: an observational real-world study. Diabetes Technol Ther. 2021;23:565\u201376.","journal-title":"Diabetes Technol Ther"},{"key":"2789_CR6","doi-asserted-by":"publisher","first-page":"5195","DOI":"10.1210\/jc.2019-00042","volume":"104","author":"EH Dahlstr\u00f6m","year":"2019","unstructured":"Dahlstr\u00f6m EH, Sandholm N, Forsblom CM, Thorn LM, Jansson FJ, Harjutsalo V, et al. Body mass index and mortality in individuals with type 1 diabetes. J Clin Endocrinol Metab. 2019;104:5195\u2013204.","journal-title":"J Clin Endocrinol Metab"},{"key":"2789_CR7","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.2337\/dc18-1446","volume":"42","author":"J Edqvist","year":"2019","unstructured":"Edqvist J, Rawshani A, Adiels M, Bj\u00f6rck L, Lind M, Svensson A-M, et al. BMI, mortality, and cardiovascular outcomes in type 1 diabetes: findings against an obesity paradox. Diabetes Care. 2019;42:1297\u2013304.","journal-title":"Diabetes Care"},{"key":"2789_CR8","doi-asserted-by":"publisher","first-page":"204201881983086","DOI":"10.1177\/2042018819830867","volume":"10","author":"G van Mark","year":"2019","unstructured":"van Mark G, Lanzinger S, Barion R, Degenhardt M, Badis S, Noll H, et al. Patient and disease characteristics of adult patients with type 1 diabetes in Germany: an analysis of the DPV and DIVE databases. Ther Adv Endocrinol Metab. 2019;10:2042018819830867.","journal-title":"Ther Adv Endocrinol Metab"},{"key":"2789_CR9","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.2337\/dc16-2523","volume":"40","author":"JQ Purnell","year":"2017","unstructured":"Purnell JQ, Braffett BH, Zinman B, Gubitosi-Klug RA, Sivitz W, Bantle JP, et al. Impact of excessive weight gain on cardiovascular outcomes in type 1 diabetes: results from the diabetes control and complications trial\/epidemiology of diabetes interventions and complications (DCCT\/EDIC) study. Diabetes Care. 2017;40:1756\u201362.","journal-title":"Diabetes Care"},{"key":"2789_CR10","doi-asserted-by":"publisher","first-page":"707","DOI":"10.2337\/dc06-1982","volume":"30","author":"ES Kilpatrick","year":"2007","unstructured":"Kilpatrick ES, Rigby AS, Atkin SL. Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: \u201cDouble diabetes\u201d in the diabetes control and complications trial. Diabetes Care. 2007;30:707\u201312.","journal-title":"Diabetes Care"},{"key":"2789_CR11","unstructured":"Rubino F, Cummings DE, Eckel RH, Cohen RV, Wilding JPH, Brown WA, et al. Definition and diagnostic criteria of clinical obesity. The Lancet Diabetes & Endocrinology [Internet]. 2025 [cited 2025 Jan 28]; Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2213858724003164"},{"key":"2789_CR12","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1161\/CIRCULATIONAHA.111.067264","volume":"126","author":"J-P Despr\u00e9s","year":"2012","unstructured":"Despr\u00e9s J-P. Body fat distribution and risk of cardiovascular disease: an update. Circulation. 2012;126:1301\u201313.","journal-title":"Circulation"},{"key":"2789_CR13","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1467-789X.2011.00952.x","volume":"13","author":"M Ashwell","year":"2012","unstructured":"Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev. 2012;13:275\u201386.","journal-title":"Obes Rev"},{"key":"2789_CR14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1017\/S0954422410000144","volume":"23","author":"LM Browning","year":"2010","unstructured":"Browning LM, Hsieh SD, Ashwell M. A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0\u00b75 could be a suitable global boundary value. Nutr Res Rev. 2010;23:247\u201369.","journal-title":"Nutr Res Rev"},{"key":"2789_CR15","doi-asserted-by":"publisher","first-page":"18575","DOI":"10.1038\/s41598-020-75667-5","volume":"10","author":"EB Parente","year":"2020","unstructured":"Parente EB, Mutter S, Harjutsalo V, Ahola AJ, Forsblom C, Groop P-H. Waist-height ratio and waist are the best estimators of visceral fat in type 1 diabetes. Sci Rep. 2020;10:18575.","journal-title":"Sci Rep"},{"key":"2789_CR16","doi-asserted-by":"publisher","first-page":"101306","DOI":"10.1016\/j.diabet.2021.101306","volume":"48","author":"JP Riveline","year":"2022","unstructured":"Riveline JP, Verg\u00e9s B, Detournay B, Picard S, Benhamou PY, Bismuth E, et al. Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: The SFDT1 study. Diabetes Metab. 2022;48:101306.","journal-title":"Diabetes Metab"},{"key":"2789_CR17","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/s12933-024-02419-4","volume":"23","author":"E Cosson","year":"2024","unstructured":"Cosson E, Auzanneau M, Aguayo GA, Karges W, Riveline J-P, Augstein P, et al. Sex inequalities in cardiovascular risk factors and their management in primary prevention in adults living with type 1 diabetes in Germany and France: findings from DPV and SFDT1. Cardiovasc Diabetol. 2024;23:342.","journal-title":"Cardiovasc Diabetol"},{"key":"2789_CR18","doi-asserted-by":"publisher","first-page":"158","DOI":"10.2337\/dc23-S010","volume":"46","author":"NA ElSayed","year":"2023","unstructured":"ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 10 Cardiovascular disease and risk management: standards of care in diabetes-2023. Diabetes Care. 2023;46:158\u201390.","journal-title":"Diabetes Care"},{"key":"2789_CR19","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1111\/j.1464-5491.2012.03644.x","volume":"29","author":"WH Herman","year":"2012","unstructured":"Herman WH, Pop-Busui R, Braffett BH, Martin CL, Cleary PA, Albers JW, et al. Use of the Michigan neuropathy screening instrument as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the diabetes control and complications trial\/epidemiology of diabetes interventions and complications. Diabetic Med J Br Diabet Assoc. 2012;29:937.","journal-title":"Diabetic Med J Br Diabet Assoc"},{"key":"2789_CR20","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1161\/CIRCULATIONAHA.115.018844","volume":"133","author":"D Vistisen","year":"2016","unstructured":"Vistisen D, Andersen GS, Hansen CS, Hulman A, Henriksen JE, Bech-Nielsen H, et al. Prediction of first cardiovascular disease event in type 1 diabetes mellitus. Circulation. 2016;133:1058\u201366.","journal-title":"Circulation"},{"key":"2789_CR21","unstructured":"Rubin DB. Multiple Imputation for Nonresponse in Surveys. Wiley, New York, pp. 251\u2013252"},{"key":"2789_CR22","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1890\/14-2200","volume":"26","author":"ME Hunsicker","year":"2016","unstructured":"Hunsicker ME, Kappel CV, Selkoe KA, Halpern BS, Scarborough C, Mease L, et al. Characterizing driver-response relationships in marine pelagic ecosystems for improved ocean management. Ecol Appl. 2016;26:651\u201363.","journal-title":"Ecol Appl"},{"key":"2789_CR23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.7570\/jomes22061","volume":"32","author":"HN Jung","year":"2023","unstructured":"Jung HN, Kim S, Jung CH, Cho YK. Association between body mass index and mortality in type 1 diabetes mellitus: a systematic review and meta-analysis. J Obes Metab Syndr. 2023;32:151\u201362.","journal-title":"J Obes Metab Syndr"},{"key":"2789_CR24","unstructured":"Lutte contre l\u2019ob\u00e9sit\u00e9: La Ligue nationale Contre l\u2019Ob\u00e9sit\u00e9 d\u00e9voile une nouvelle \u00e9tude \u00e9pid\u00e9miologique OF\u00c9O| Ligue nationale Contre l\u2019Ob\u00e9sit\u00e9 [Internet]. [cited 2024 Nov 15]. Available from: https:\/\/liguecontrelobesite.org\/actualite\/lutte-contre-lobesite-la-ligue-nationale-contre-lobesite-devoile-une-nouvelle-etude-epidemiologique-ofeo\/"},{"key":"2789_CR25","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/j.1464-5491.2010.02956.x","volume":"27","author":"B Conway","year":"2010","unstructured":"Conway B, Miller RG, Costacou T, Fried L, Kelsey S, Evans RW, et al. Temporal patterns in overweight and obesity in Type 1 diabetes. Diabet Med. 2010;27:398\u2013404.","journal-title":"Diabet Med"},{"key":"2789_CR26","doi-asserted-by":"publisher","first-page":"e2032","DOI":"10.1210\/clinem\/dgaa015","volume":"105","author":"VN Shah","year":"2020","unstructured":"Shah VN, Bailey R, Wu M, Foster NC, Pop-Busui R, Katz M, et al. Risk factors for cardiovascular disease (CVD) in adults with type 1 diabetes: findings from prospective real-life T1D exchange registry. J Clin Endocrinol Metab. 2020;105:e2032\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"2789_CR27","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41574-019-0310-7","volume":"16","author":"R Ross","year":"2020","unstructured":"Ross R, Neeland IJ, Yamashita S, Shai I, Seidell J, Magni P, et al. Waist circumference as a vital sign in clinical practice: a consensus statement from the IAS and ICCR working group on visceral obesity. Nat Rev Endocrinol. 2020;16:177\u201389.","journal-title":"Nat Rev Endocrinol"},{"key":"2789_CR28","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1590\/2359-3997000000220","volume":"60","author":"LGG Porto","year":"2016","unstructured":"Porto LGG, Nogueira RM, Nogueira EC, Molina GE, Farioli A, Junqueira LF, et al. Agreement between BMI and body fat obesity definitions in a physically active population. Arch Endocrinol Metab. 2016;60:515\u201325.","journal-title":"Arch Endocrinol Metab"},{"key":"2789_CR29","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1590\/2359-3997000000232","volume":"60","author":"EB Parente","year":"2016","unstructured":"Parente EB. Is body mass index still a good tool for obesity evaluation? Arch Endocrinol Metab. 2016;60:507\u20139.","journal-title":"Arch Endocrinol Metab"},{"key":"2789_CR30","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.2337\/dc20-3175","volume":"44","author":"EB Parente","year":"2021","unstructured":"Parente EB, Dahlstr\u00f6m EH, Harjutsalo V, Inkeri J, Mutter S, Forsblom C, et al. The relationship between body fat distribution and nonalcoholic fatty liver in adults with type 1 diabetes. Diabetes Care. 2021;44:1706\u201313.","journal-title":"Diabetes Care"},{"key":"2789_CR31","doi-asserted-by":"publisher","first-page":"e653","DOI":"10.1210\/clinem\/dgab671","volume":"107","author":"EB Parente","year":"2022","unstructured":"Parente EB, Harjutsalo V, Forsblom C, Groop P-H. Waist-height ratio and the risk of severe diabetic eye disease in type 1 diabetes: a 15-year cohort study. J Clin Endocrinol Metab. 2022;107:e653\u201362.","journal-title":"J Clin Endocrinol Metab"},{"key":"2789_CR32","doi-asserted-by":"crossref","unstructured":"Parente EB, Harjutsalo V, Forsblom C, Groop P-H, FinnDiane Study Group. The impact of central obesity on the risk of hospitalization or death due to heart failure in type 1 diabetes: a 16-year cohort study. Cardiovasc Diabetol. 2021;20:153.","DOI":"10.1186\/s12933-021-01340-4"},{"key":"2789_CR33","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-1935","author":"E Parente","year":"2023","unstructured":"Parente E, Mutter S, Thorn L, Harjutsalo V, Groop P-H. Relationship between abdominal fatness and onset and progression of albuminuria in type 1 diabetes. Diabetes Care. 2023. https:\/\/doi.org\/10.2337\/dc22-1935.","journal-title":"Diabetes Care"},{"key":"2789_CR34","doi-asserted-by":"publisher","first-page":"954","DOI":"10.3945\/jn.109.118737","volume":"140","author":"A Bosy-Westphal","year":"2010","unstructured":"Bosy-Westphal A, Booke C-A, Bl\u00f6cker T, Kossel E, Goele K, Later W, et al. Measurement site for waist circumference affects its accuracy as an index of visceral and abdominal subcutaneous fat in a Caucasian population 1,2. J Nutr. 2010;140:954\u201361.","journal-title":"J Nutr"},{"key":"2789_CR35","doi-asserted-by":"publisher","first-page":"416","DOI":"10.20945\/2359-3997000000055","volume":"62","author":"CPS Pinho","year":"2018","unstructured":"Pinho CPS, da Diniz AS, de Arruda IKG, Leite APDL, Petribu M, de Moraes Vasconcelos Petribu MV, Rodrigues IG. Waist circumference measurement sites and their association with visceral and subcutaneous fat and cardiometabolic abnormalities. Arch Endocrinol Metab. 2018;62:416\u201323.","journal-title":"Arch Endocrinol Metab."},{"key":"2789_CR36","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41569-023-00926-7","volume":"21","author":"JM Mehta","year":"2024","unstructured":"Mehta JM, Manson JE. The menopausal transition period and cardiovascular risk. Nat Rev Cardiol. 2024;21:203\u201311.","journal-title":"Nat Rev Cardiol"},{"key":"2789_CR37","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1186\/s12933-024-02460-3","volume":"23","author":"IC Paliares","year":"2024","unstructured":"Paliares IC, Dualib PM, Torres LSN, Aroucha PMT, de Almeida-Pititto B, de Sa JR, et al. Evaluation of the steno type 1 risk engine in predicting cardiovascular events in an ethnic mixed population of type 1 diabetes mellitus and its association with chronic microangiopathy complications. Cardiovasc Diabetol. 2024;23:374.","journal-title":"Cardiovasc Diabetol"},{"key":"2789_CR38","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12933-024-02145-x","volume":"23","author":"W Bielka","year":"2024","unstructured":"Bielka W, Przezak A, Mol\u0119da P, Pius-Sadowska E, Machali\u0144ski B. Double diabetes-when type 1 diabetes meets type 2 diabetes: definition, pathogenesis and recognition. Cardiovasc Diabetol. 2024;23:62.","journal-title":"Cardiovasc Diabetol"},{"key":"2789_CR39","doi-asserted-by":"publisher","first-page":"306","DOI":"10.2337\/db10-0328","volume":"60","author":"IE Schauer","year":"2011","unstructured":"Schauer IE, Snell-Bergeon JK, Bergman BC, Maahs DM, Kretowski A, Eckel RH, et al. Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study. Diabetes. 2011;60:306\u201314.","journal-title":"Diabetes"},{"key":"2789_CR40","doi-asserted-by":"publisher","first-page":"826","DOI":"10.2337\/diab.41.7.826","volume":"41","author":"M-C Pouliot","year":"1992","unstructured":"Pouliot M-C, Despres J-P, Nadeau A, Moorjani S, Prud\u2019Homme D, Lupien PJ, et al. Visceral obesity in men, associations with glucose tolerance, plasma insulin, and lipoprotein levels. Diabetes. 1992;41:826\u201334.","journal-title":"Diabetes"},{"key":"2789_CR41","doi-asserted-by":"publisher","first-page":"304","DOI":"10.2337\/diab.38.3.304","volume":"38","author":"JP Despr\u00e9s","year":"1989","unstructured":"Despr\u00e9s JP, Nadeau A, Tremblay A, Ferland M, Moorjani S, Lupien PJ, et al. Role of deep abdominal fat in the association between regional adipose tissue distribution and glucose tolerance in obese women. Diabetes. 1989;38:304\u20139.","journal-title":"Diabetes"},{"key":"2789_CR42","doi-asserted-by":"publisher","first-page":"633","DOI":"10.2337\/diab.45.5.633","volume":"45","author":"DG Carey","year":"1996","unstructured":"Carey DG, Jenkins AB, Campbell LV, Freund J, Chisholm DJ. Abdominal fat and insulin resistance in normal and overweight women: Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes. 1996;45:633\u20138.","journal-title":"Diabetes"},{"key":"2789_CR43","doi-asserted-by":"publisher","first-page":"117158","DOI":"10.1016\/j.atherosclerosis.2023.06.005","volume":"394","author":"B Verg\u00e8s","year":"2023","unstructured":"Verg\u00e8s B. Cardiovascular disease in type 1 diabetes, an underestimated danger: Epidemiological and pathophysiological data. Atherosclerosis. 2023;394:117158.","journal-title":"Atherosclerosis"},{"key":"2789_CR44","doi-asserted-by":"publisher","first-page":"e15377","DOI":"10.1111\/dme.15377","volume":"41","author":"R Frampton","year":"2024","unstructured":"Frampton R, Snaith JR, Hocking S, Holmes-Walker J, Olsen N, Greenfield JR. Reducing cardiometabolic risk with semaglutide in type 1 diabetes (RESET1): study protocol of a phase 2 double-blinded randomised placebo-controlled trial. Diabet Med. 2024;41:e15377.","journal-title":"Diabet Med"},{"key":"2789_CR45","doi-asserted-by":"publisher","DOI":"10.1177\/19322968241289438","author":"P Holmager","year":"2024","unstructured":"Holmager P, Christensen MB, N\u00f8rgaard K, Schmidt S. GLP-1 receptor agonists in overweight and obese individuals with type 1 diabetes using an automated insulin delivery device: a real-world study. J Diabetes Sci Technol. 2024. https:\/\/doi.org\/10.1177\/19322968241289438.","journal-title":"J Diabetes Sci Technol"},{"key":"2789_CR46","doi-asserted-by":"publisher","first-page":"237437352412578","DOI":"10.1177\/23743735241257811","volume":"11","author":"BD Lamaro","year":"2024","unstructured":"Lamaro BD, Greenfield JR, Snaith JR. Can unmet needs be addressed by adjunctive therapies? Findings from a patient perspectives survey in adults with type 1 diabetes. J Patient Exp. 2024;11:23743735241257812.","journal-title":"J Patient Exp"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02789-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-02789-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02789-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T07:59:16Z","timestamp":1749887956000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-025-02789-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,14]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2789"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-02789-3","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,14]]},"assertion":[{"value":"14 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"SFDT1 was approved by an ethical committee on 5 November 2019 and is declared in clinical trial NCT04657783.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"EBP reports receiving lecture honorariums from Astra Zeneca and Sanofi, and has been an employee of Boehringer Ingelheim since February 2024. The other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"256"}}